StreetInsider.com News Articles

Form 4 Paysign, Inc. For: Feb 28 Filed by: Baker Jeffery Bradford

Mon, 02 Mar 2026 16:03:00 -0500

si-local-file:///var/storage/secattach/20260302/26091833.html

Form 4 Paysign, Inc. For: Feb 28 Filed by: Baker Jeffery Bradford

Mon, 02 Mar 2026 16:03:00 -0500

si-local-file:///var/storage/secattach/20260302/26091833.html

Paysign to Host Fourth Quarter and Full Year 2025 Earnings Call

Tue, 24 Feb 2026 16:30:00 -0500

HENDERSON, Nev.--(BUSINESS WIRE)-- Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, will discuss fourth quarter and full year 2025 earnings at 5:00 p.m. Eastern time on Tuesday, March 24, 2026.

Participant details are as follows:
U.S. dial-in: 877.407.2988
International dial-in: +1.201.389.0923
Webcast: Click Here

Replay:
Dial-in: 877.660.6853 or +1.201.612.7415
Conference ID: 13758162
The replay will be available until June 24, 2026.

To register as a financial professional in order to ask questions during

Paysign to Host Fourth Quarter and Full Year 2025 Earnings Call

Tue, 24 Feb 2026 16:30:00 -0500

Participant details are as follows:
U.S. dial-in: 877.407.2988
International dial-in: +1.201.389.0923
Webcast: Click Here

Replay:
Dial-in: 877.660.6853 or +1.201.612.7415
Conference ID: 13758162
The replay will be available until June 24, 2026.

To register as a financial professional in order to ask questions during

Paysign to Host Fourth Quarter and Full Year 2025 Earnings Call

Tue, 24 Feb 2026 16:30:00 -0500

Participant details are as follows:
U.S. dial-in: 877.407.2988
International dial-in: +1.201.389.0923
Webcast: Click Here

Replay:
Dial-in: 877.660.6853 or +1.201.612.7415
Conference ID: 13758162
The replay will be available until June 24, 2026.

To register as a financial professional in order to ask questions during

Paysign to Host Fourth Quarter and Full Year 2025 Earnings Call

Tue, 24 Feb 2026 16:30:00 -0500

Participant details are as follows:
U.S. dial-in: 877.407.2988
International dial-in: +1.201.389.0923
Webcast: Click Here

Replay:
Dial-in: 877.660.6853 or +1.201.612.7415
Conference ID: 13758162
The replay will be available until June 24, 2026.

To register as a financial professional in order to ask questions during

Paysign, Inc. to Present at the Oppenheimer 11th Annual Emerging Growth Conference

Wed, 21 Jan 2026 16:30:00 -0500

HENDERSON, Nev.--(BUSINESS WIRE)-- Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced it will be presenting at the Oppenheimer 11th Annual Emerging Growth Conference to be held February 3-4, 2026, through a virtual format.

The focus of the virtual conference is to feature one-on-one and small group meetings with emerging companies in technology, industrial growth and consumer sectors. Paysign’s Chief Financial Officer, Jeff Baker, will host one-on-one meetings on Tuesday, February 3.

Investors interested in

Paysign, Inc. to Present at the Oppenheimer 11th Annual Emerging Growth Conference

Wed, 21 Jan 2026 16:30:00 -0500

HENDERSON, Nev.--(BUSINESS WIRE)-- Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced it will be presenting at the Oppenheimer 11th Annual Emerging Growth Conference to be held February 3-4, 2026, through a virtual format.

Investors interested in

Paysign, Inc. to Present at the Oppenheimer 11th Annual Emerging Growth Conference

Wed, 21 Jan 2026 16:30:00 -0500

HENDERSON, Nev.--(BUSINESS WIRE)-- Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced it will be presenting at the Oppenheimer 11th Annual Emerging Growth Conference to be held February 3-4, 2026, through a virtual format.

Investors interested in

Paysign, Inc. to Present at the Oppenheimer 11th Annual Emerging Growth Conference

Wed, 21 Jan 2026 16:30:00 -0500

HENDERSON, Nev.--(BUSINESS WIRE)-- Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced it will be presenting at the Oppenheimer 11th Annual Emerging Growth Conference to be held February 3-4, 2026, through a virtual format.

Investors interested in

DA Davidson Reiterates Buy Rating on Paysign Inc. (PAYS) Following Patient Affordability Update

Thu, 08 Jan 2026 09:12:29 -0500

DA Davidson analyst Peter Heckmann reiterated a Buy rating and $9.00 price target on Paysign Inc. (NASDAQ: PAYS).

The analyst commented, "Paysign announced the company exited the year with 131 Pharma patient affordability programs, an increase of 72% over 2024. For 2025, we are forecasting Pharmaceutical Patient Affordability segment revenue increased by 156% Y/Y to $32.4M (40% of total revenue). The ending program count of 131 matched our current forecast. We are maintaining our BUY rating on Paysign and our price target of $9 per share."

For an analyst ratings summary and ratings history on Paysign Inc. click here. For more

Paysign, Inc. Announces 2025 Performance Analysis of Patient Affordability Solutions

Wed, 07 Jan 2026 08:05:00 -0500

Dynamic Business Rules Demonstrates the Company’s Advanced Capabilities in Mitigating Copay Maximizers, Exiting 2025 With 131 Active Programs

HENDERSON, Nev.--(BUSINESS WIRE)-- Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions and integrated payment processing for the life sciences industries, today announced its annual performance analysis of pharmaceutical copay programs. The company added 55 programs during 2025, exiting the year with 131 programs – many incorporating Paysign’s Dynamic Business Rules feature, which saved pharmaceutical clients more than $325 million by mitigating the harmful financial impact of copay maximizers on patients

Paysign, Inc. Announces 2025 Performance Analysis of Patient Affordability Solutions

Wed, 07 Jan 2026 08:05:00 -0500

Dynamic Business Rules Demonstrates the Company’s Advanced Capabilities in Mitigating Copay Maximizers, Exiting 2025 With 131 Active Programs

Paysign, Inc. Announces 2025 Performance Analysis of Patient Affordability Solutions

Wed, 07 Jan 2026 08:05:00 -0500

Dynamic Business Rules Demonstrates the Company’s Advanced Capabilities in Mitigating Copay Maximizers, Exiting 2025 With 131 Active Programs

Paysign, Inc. Announces 2025 Performance Analysis of Patient Affordability Solutions

Wed, 07 Jan 2026 08:05:00 -0500

Dynamic Business Rules Demonstrates the Company’s Advanced Capabilities in Mitigating Copay Maximizers, Exiting 2025 With 131 Active Programs

Form 4 Paysign, Inc. For: Dec 12 Filed by: Strobo Robert

Fri, 12 Dec 2025 18:08:00 -0500

si-local-file:///var/storage/secattach/20251212/25735822.html

Form 4 Paysign, Inc. For: Dec 12 Filed by: Strobo Robert

Fri, 12 Dec 2025 18:08:00 -0500

si-local-file:///var/storage/secattach/20251212/25735822.html

DA Davidson Reiterates Buy Rating on Paysign Inc. (PAYS)

Fri, 14 Nov 2025 09:39:51 -0500

DA Davidson analyst Peter Heckmann reiterated a Buy rating and $9.00 price target on Paysign Inc. (NASDAQ: PAYS).

The analyst commented, "Paysign reported strong 3Q results, with 42% Y/Y revenue growth and 78% Y/Y growth in adjusted EBITDA (7% and 10% above our forecasts, respectively). With 3Q results, management raised the midpoints of their prior guidance ranges for total revenue and adjusted EBITDA by 5% and 3%, respectively. We are maintaining our BUY rating on Paysign and our $9 price target."

For an analyst ratings summary and ratings history on Paysign Inc. click here. For more ratings news on Paysign Inc.

Paysign, Inc. to Present at the 17th Annual Southwest IDEAS Investor Conference

Thu, 13 Nov 2025 16:30:00 -0500

HENDERSON, Nev.--(BUSINESS WIRE)-- Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced they will be presenting at the 17th Annual Southwest IDEAS Investor Conference to be held Wednesday and Thursday, November 19 and 20, 2025, in Dallas, Texas.

The conference is an annual invitation-only event, featuring quality public companies to interact with top institutional investors. The format has been designed to give attendees direct access to senior management via one-on-one and group meeting formats.

Paysign’s

Paysign, Inc. to Present at the 17th Annual Southwest IDEAS Investor Conference

Thu, 13 Nov 2025 16:30:00 -0500

HENDERSON, Nev.--(BUSINESS WIRE)-- Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced they will be presenting at the 17th Annual Southwest IDEAS Investor Conference to be held Wednesday and Thursday, November 19 and 20, 2025, in Dallas, Texas.

Paysign’s

Paysign, Inc. to Present at the 17th Annual Southwest IDEAS Investor Conference

Thu, 13 Nov 2025 16:30:00 -0500

HENDERSON, Nev.--(BUSINESS WIRE)-- Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced they will be presenting at the 17th Annual Southwest IDEAS Investor Conference to be held Wednesday and Thursday, November 19 and 20, 2025, in Dallas, Texas.

Paysign’s

Paysign, Inc. to Present at the 17th Annual Southwest IDEAS Investor Conference

Thu, 13 Nov 2025 16:30:00 -0500

HENDERSON, Nev.--(BUSINESS WIRE)-- Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced they will be presenting at the 17th Annual Southwest IDEAS Investor Conference to be held Wednesday and Thursday, November 19 and 20, 2025, in Dallas, Texas.

Paysign’s

Form 10-Q Paysign, Inc. For: Sep 30

Thu, 13 Nov 2025 07:18:00 -0500

si-local-file:///var/storage/secattach/20251113/25602138.html

Form 10-Q Paysign, Inc. For: Sep 30

Thu, 13 Nov 2025 07:18:00 -0500

si-local-file:///var/storage/secattach/20251113/25602138.html

Form 8-K Paysign, Inc. For: Nov 12

Wed, 12 Nov 2025 17:10:00 -0500

si-local-file:///var/storage/secattach/20251112/25599629.html